A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy

• Principais autores: Fumie Hanawa (Autor), Takashi Inozume (Autor), Kazutoshi Harada (Autor), Tatsuyosi Kawamura (Autor), Naotaka Shibagaki (Autor), Shinji Shimada (Autor)
• Formato: Livro
• Publicado em: Karger Publishers, 2011-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

There is no effective treatment for advanced extramammary Paget's disease (EMPD). The human epidermal growth factor receptor 2 (HER2) protein is often overexpressed in EMPD. Trastuzumab is a humanized monoclonal antibody against HER2 used in the treatment of breast cancers in which HER2 is over...